Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Proleukocyte AB
AB
Active
Org 5593917478
Economic activity was not specified by tax authority · NACE 0000
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
—
—
Net profit
SEK 0
+100%
Total assets
SEK 25K
+10%
Equity
SEK 25K
+10%
Employees
0
—
Company information
Legal name
Proleukocyte AB
Org number
5593917478
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
8 augusti 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av Kiessling, Rolf Valter Rikard Wickström, Stina Linnéa
Company purpose
Forsknings och utvecklingsarbete av immunterapiläkemedel med särskild inriktning på cellterapi.
Contact
Address
Email
wickstrom.stina@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−2
—
Depreciation & amort.
—
—
EBIT
−2
0
Net financials
—
—
Profit before tax
−2
0
Tax
—
—
Net profit
−2
0
Balance sheet
SEK thousands
Item
2023
2024
Total assets
23
25
Equity
23
25
Long-term debt
0
0
Short-term debt
0
0
Total debt
—
—
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2023
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2023
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2023
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-08 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KK
Klas Kärre
Board of Directors
2022
RV
Rolf Valter Rikard Kiessling
Board of Directors
2022
SL
Stina Linnéa Wickström
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Proleukocyte AB also hold positions in
0
other companies.
Person
Role here
Other companies
Klas Kärre
Board of Directors
0 companies
Rolf Valter Rikard Kiessling
Board of Directors
0 companies
Stina Linnéa Wickström
Chairman
0 companies